Cover Image

Nivolumab associated vasculopathy: A novel mechanism

Saved in:

Bibliographic Details
Main Authors:	Adeeb Haroon, MS (Author), James K. Parker, MD (Author), Kara Braudis, MD (Author), Emily H. Smith, MD (Author)
Format:	Book
Published:	Elsevier, 2022-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Nivolumab-associated cutaneous T-cell lymphoma
by: Jennifer A. Marks, MD, et al.
Published: (2021)

Botulinum toxin-A: A novel treatment for livedoid vasculopathy
by: Angela M. Crotty, MD, et al.
Published: (2022)

Nivolumab-associated vitiligo-like depigmentation in a patient with acute myeloid leukemia: A novel finding
by: Emily S. Yin, BS, et al.
Published: (2017)

Eosinophilic fasciitis in association with nivolumab: The importance of eosinophilia
by: Gabriela Pabón-Cartagena, MD, et al.
Published: (2020)

Inverse lichenoid drug eruption associated with nivolumab
by: Lauren M. Guggina, MD, et al.
Published: (2017)

Psoriasiform eruption on the face and extremities associated with nivolumab therapy
by: Amit Om, MD, et al.
Published: (2018)

Bullous pemphigoid in a metastatic lung cancer patient associated with nivolumab
by: Yuka Maya, MD, et al.
Published: (2020)

Livedoid vasculopathy: A multidisciplinary clinical approach to diagnosis and management
by: Asli Bilgic, MD, et al.
Published: (2021)

Postoperative permanent section evaluation of Mohs micrographic surgery debulk specimens does not result in upstaging of cutaneous squamous cell carcinoma compared to stage at the completion of surgery: A retrospective case seriesCapsule Summary
by: Andrea Gilmore, MD, et al.
Published: (2024)

Ulcerative livedoid vasculopathy responding to clopidogrel
by: Elaine Kunzler, BS, et al.
Published: (2018)

Pseudoangiosarcoma and cutaneous collagenous vasculopathy in a patient on a Bruton's tyrosine kinase inhibitor
by: Alison H. Kucharik, MD, et al.
Published: (2024)

Thrombotic vasculopathy due to polymer coating emboli after an endovascular procedure
by: Roya S. Nazarian, MD, et al.
Published: (2021)

Toxic epidermal necrolysis (TEN) associated with the use of nivolumab (PD-1 inhibitor) for lymphoma
by: Liezel L. Griffin, MBBS, et al.
Published: (2018)

Postsurgical skin ulcers caused by cytomegalovirus vasculopathy in a renal transplant recipient
by: Shikha Rao, MD, et al.
Published: (2020)

Nivolumab-related cutaneous sarcoidosis in a patient with lung adenocarcinoma
by: Mathew R. Birnbaum, BS, et al.
Published: (2017)

A case of livedoid vasculopathy, a thrombotic occlusive vasculopathy
by: Anais Huot, et al.
Published: (2022)

Livedoid vasculopathy
by: Thiago Quadrante Freitas, et al.
Published: (2018)

Hyponatremia and Fever in a Patient on Ipilimumab and Nivolumab (Immune Checkpoint Inhibitors): A Case Report
by: Sumit S. Patel MD, et al.
Published: (2021)

A case of nivolumab-induced scleroderma-like syndrome successfully treated with intravenous immunoglobulin
by: Alexa DeMaio, MD, et al.
Published: (2023)

Risk of immune-related adverse events associated with ipilimumab-plus-nivolumab and nivolumab therapy in cancer patients
by: Zhou S, et al.
Published: (2019)

Long-term response of vulvar mucosal melanoma treated with neoadjuvant nivolumab
by: Margaux Dubus, MD, et al.
Published: (2023)

The Vasculopathy of Juvenile Dermatomyositis
by: Charalampia Papadopoulou, et al.
Published: (2018)

Resolution of paraneoplastic alopecia areata following nivolumab in a patient with metastatic melanoma
by: Sophia Wix, MPhil, et al.
Published: (2023)

LIPID TRENDS ON DONOR DERIVED ATHEROSCLEROTIC DISEASE AND ALLOGRAFT VASCULOPATHY IN HEART TRANSPLANT RECIPIENTS AT A LARGE ACADEMIC CENTER
by: Antoinette S. Birs, MD, et al.
Published: (2023)

Rivaroxaban in the treatment of livedoid vasculopathy: A long-term retrospective study
by: Sihan Deng, BS, et al.
Published: (2024)

Vasculitis and vasculopathy associated with inborn errors of immunity: an overview
by: Silvia Federici, et al.
Published: (2024)

Eosinophilic fasciitis induced by nivolumab therapy managed without treatment interruption or systemic immunosuppression
by: Ai-Tram N. Bui, BA, et al.
Published: (2020)

Nivolumab-induced psoriasis successfully treated with risankizumab-rzaa in a patient with stage III melanoma
by: George D. Glinos, MD, et al.
Published: (2021)

Lupus vasculopathy- An underappreciated pathology
by: Gaurav Kumar Khandelwal, et al.
Published: (2022)

Varicella Zoster Virus Vasculopathies
by: J Gordon Millichap
Published: (2008)

Herbal Supplements and Cerebral Vasculopathy
by: J Gordon Millichap
Published: (2005)

Nivolumab-induced lichen planus responsive to dupilumab treatment in a patient with stage III C melanoma
by: Sarah Kamsiah Zemlok, BA, et al.
Published: (2023)

Lenticulostriate Vasculopathy in Brain Ultrasonography is Associated with Cytomegalovirus Infection in Newborns
by: Syuan-Yu Hong, et al.
Published: (2015)

Vasculopathy associated with peripheral neuropathy in gait parameters of diabetic people
by: Alessandra Madia Mantovani, et al.

Lichen striatus as an immune-related adverse event following ipilimumab/nivolumab and COVID-19 infection in an adult
by: Courtney M. Kenyon, BS, et al.
Published: (2024)

Livedoid vasculopathy associated with peripheral neuropathy: a report of two cases
by: Mariana Quirino Tubone, et al.
Published: (2013)

A case of concomitant clinical and histopathologic features of lymphocytic thrombophilic arteritis and livedoid vasculopathy
by: Christian Gan, BMedSci, MD, et al.
Published: (2023)

Successful treatment of HIV-negative Kaposi sarcoma with ipilimumab and nivolumab and concurrent management of baseline psoriasis and bullous pemphigoid
by: Mika M. Tabata, BS, et al.
Published: (2020)

Case Report: Necrotizing Stomatitis as a Manifestation of COVID-19-Associated Vasculopathy
by: Nina Emeršič, et al.
Published: (2021)

A Case of Nivolumab-Induced Cutaneous Toxicity with Multiple Morphologies
by: Emily D. Nguyen, et al.
Published: (2020)